National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 23837 [2020-09049]
Download as PDF
23837
Federal Register / Vol. 85, No. 83 / Wednesday, April 29, 2020 / Notices
individual’s last name, first name, date
of birth, gender, language, race,
ethnicity, address, phone number,
insurance carrier name, and whether the
individual has provided informed
consent and received a copy of the
privacy notice. The information from
the Lab Requisition form is shared with
the ordering provider, the contracted
laboratory companies, the cognizant
state health department, and the
contracted call center. Aggregate data is
shared with HHS and FEMA.
ESTIMATED ANNUALIZED BURDEN TABLE
Type of respondent
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Individuals receiving COVID–19 testing ..........................................................
200,000
1
.1
20,000
[FR Doc. 2020–09039 Filed 4–28–20; 8:45 am]
Dated: April 23, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4150–36–P
[FR Doc. 2020–09047 Filed 4–28–20; 8:45 am]
Sherrette A. Funn,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Clinical
Cognitive Screening.
Date: May 18, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892. (Telephone Conference
Call)
Contact Person: Greg Bissonette, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, BETHESDA,
MD 20892, (301) 402–1622, bissonettegb@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
20:00 Apr 28, 2020
Jkt 250001
Dated: April 23, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–09049 Filed 4–28–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
and Hematology Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group Digestive Diseases and
Nutrition DDK–C Subcommittee.
Date: June 17–19, 2020.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6706
Democracy Blvd., Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, Division of Extramural Activities,
NIDDK, National Institutes of Health, Room
7017, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7637, davilabloomm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel;
P41 BTRC Review F–SEP.
Date: June 10–12, 2020.
Time: 09:00 a.m. to 05:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Rockville, MD 20852.
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, National
Institute of Biomedical Imaging, and
Bioengineering, National Institutes of
Health, 6707 Democracy Blvd.,
E:\FR\FM\29APN1.SGM
29APN1
Agencies
[Federal Register Volume 85, Number 83 (Wednesday, April 29, 2020)]
[Notices]
[Page 23837]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09049]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group Digestive Diseases and
Nutrition DDK-C Subcommittee.
Date: June 17-19, 2020.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6706 Democracy Blvd.,
Bethesda, MD 20892. (Telephone Conference Call)
Contact Person: Maria E. Davila-Bloom, Ph.D., Scientific Review
Officer, Review Branch, Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7017, 6707 Democracy Boulevard,
Bethesda, MD 20892-5452, (301) 594-7637, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: April 23, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-09049 Filed 4-28-20; 8:45 am]
BILLING CODE 4140-01-P